They even left out the biggest point, from my point of view. That Leo said very soon in The Boston Business Journal after full well knowing the FDA requested more information before granting phase 3 for B-ABSSSI.
My trust in Leo was damaged some from that, since he had previously talked about up-listing in years past.
Something happened - which unleashed the power of our imagination...